Piperlongumine Selectively Kills Hepatocellular Carcinoma Cells and Preferentially Inhibits Their Invasion Via ROS-ER-MAPKs-CHOP
Overview
Authors
Affiliations
Hepatocellular carcinomas (HCC) are highly malignant and aggressive tumors lack of effective therapeutic drugs. Piperlongumine (PL), a natural product isolated from longer pepper plants, is recently identified as a potent cytotoxic compound highly selective to cancer cells. Here, we reported that PL specifically suppressed HCC cell migration/invasion via endoplasmic reticulum (ER)-MAPKs-CHOP signaling pathway. PL selectively killed HCC cells but not normal hepatocytes with an IC50 of 10-20 µM while PL at much lower concentrations only suppressed HCC cell migration/invasion. PL selectively elevated reactive oxygen species (ROS) in HCC cells, which activated or up-regulated downstream PERK/Ire 1α/Grp78, p38/JNK/Erk and CHOP subsequently. Administration of antioxidants completely abolished PL's effects on cell death and migration/invasion. However, pharmacological inhibition of ER stress-responses or MAPKs signaling pathways with corresponding specific inhibitors only reversed PL's effect on cell migration/invasion but not on cell death. Consistently, knocking-down of CHOP by RNA interference only reversed PL-suppressed HCC cell migration. Finally, PL significantly suppressed HCC development and activated the ER-MAPKs-CHOP signaling pathway in HCC xenografts in vivo. Taken together, PL selectively killed HCC cells and preferentially inhibited HCC cell migration/invasion via ROS-ER-MAPKs-CHOP axis, suggesting a novel therapeutic strategy for the highly malignant and aggressive HCC clinically.
The metabolites from traditional Chinese medicine targeting ferroptosis for cancer therapy.
Tang Y, Zhuang Y, Zhao C, Gu S, Zhang J, Bi S Front Pharmacol. 2024; 15:1280779.
PMID: 39021832 PMC: 11251977. DOI: 10.3389/fphar.2024.1280779.
Piperlongumine regulates genes involved in the skin barrier in epidermal keratinocyte HaCaT cells.
Lee K, Kang D, Kim D, Do H, Kim D, Kim W Anim Cells Syst (Seoul). 2024; 28(1):326-339.
PMID: 38933927 PMC: 11207940. DOI: 10.1080/19768354.2024.2361144.
Kang H, Truong Hoang Q, Min J, Son M, Tram L, Kim B Int J Mol Sci. 2024; 25(6).
PMID: 38542447 PMC: 10971048. DOI: 10.3390/ijms25063474.
Mohan S, Alhazmi H, Hassani R, Khuwaja G, Maheshkumar V, Aldahish A Heliyon. 2024; 10(3):e24786.
PMID: 38314277 PMC: 10837572. DOI: 10.1016/j.heliyon.2024.e24786.
Tripathi S, Sahoo R, Biswal B Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5631-5647.
PMID: 38280008 DOI: 10.1007/s00210-024-02965-4.